PROject - Supportive and Palliative Care and INnOvation - Antwerp (Pro-Spinoza)

Palliative Care Clinical Trial

— pro-Spinoza  

Official title:

Implementation of the Care Pathway for Primary Palliative Care in Five Research Clusters in Belgium

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02266069
• Other study ID #: UA C130298
• Status: Completed
• Phase: N/A
• First received: October 10, 2014
• Last updated: November 27, 2017
• Start date: October 2014
• Est. completion date: December 2016

Study information

• Verified date: November 2017
• Source: Universiteit Antwerpen
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

It is important to provide high quality palliative care to all patients with a non-curable and life-limiting condition. The Care Pathway for Primary Palliative Care (CPPPC) provides tools for health care professionals to help them delivering palliative care timely and accurately.This study investigates whether the implementation of the CPPPC really helps to improve patients' lifes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 24
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• identified as a palliative care patient using the Surprise Question "Would you, as a family doctor, be surprised if this patient would die in the next 12 months?". If the answer is 'no', the patient is eligible for the study.

Exclusion Criteria:

• not having signed the informed consent.

Related Conditions & MeSH terms

• Palliative Care
• Primary Health Care

Intervention

Other:
• Care Pathway for Primary Palliative Care
Early identification of palliative care patients, anticipatory care planning, systematic symptom assessment, interdisciplinary collaboration, rigorous follow-up of the functional status of the patient and giving attention to the informal care givers.

Locations

Country	Name	City	State
Belgium	Palliatieve Hulpverlening Antwerpen	Antwerp
Belgium	Palliabru	Brussels-Capital Region
Belgium	Netwerk Palliatieve Zorg Limburg	Hasselt	Limburg
Belgium	Reliance	Mons	Hainaut

Sponsors (3)

Lead Sponsor	Collaborator
Bert Leysen	InterMutualistic Agency, Belgium, National Institute for Health and Disability Insurance, Belgium

Country where clinical trial is conducted

Belgium, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	percentage of deaths occurred in the hospital (of patients per family doctor/per research cluster)	The hypothesis is that the CPPPC reduces the percentage of deaths occurred in the hospital	6 months
Secondary	cost of health care consumption in the last year of life (of patients per family doctor/per research cluster)	The hypothesis is that the CPPPC reduces the cost of health care consumption in the last year of life	6 months
Secondary	consumption of antibiotics in the last year of life (of patients per family doctor/per research cluster)	The hypothesis is that the CPPPC reduces the consumption of antibiotics in the last year of life	6 months
Secondary	consumption of pain killers in the last year of life (of patients per family doctor/per research cluster)	The hypothesis is that the CPPPC augments the consumption of pain killers in the last year of life	6 months
Secondary	consumption of (invasive) diagnostic and therapeutic procedures in the last year of life (of patients per family doctor/per research cluster)	The hypothesis is that the CPPPC reduces the consumption of (invasive) diagnostic and therapeutic procedures in the last year of life	6 months

External Links

•   Link